rhenium has been researched along with Glioma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, R; Li, B; Liang, S; Ma, Y; Miao, Y; Shi, S; Xi, Y; Zhang, M | 1 |
| Chang, CH; Chang, CW; Chen, LC; Hsu, WH; Huang, FY; Lee, TW; Lo, JM | 1 |
| Brust, P; Chen, X; Chen, Y; Deuther-Conrad, W; Dong, C; Jia, B; Jia, H; Li, D; Liu, B; Steinbach, J; Wang, X | 1 |
| Belloche, C; Benoît, JP; Couturier, OF; Garcion, E; Hindré, F; Lacoeuille, F; LeJeune, JJ; Lemaire, L; Lepareur, N; Menei, P; Vanpouille-Box, C | 1 |
| Chang, CH; Chen, WJ; Huang, FY; Kao, CH; Lee, TW; Lee, WY; Lo, JM; Wang, SC; Zhang, X | 1 |
| Bao, A; Brenner, AJ; Goins, B; Guttierez, JE; Henry, J; Miller, JR; Phillips, WT; Trevino, A; Vargas, D; Vecil, G; Zuniga, R | 1 |
| James, CD | 1 |
| Barth, RF; Cho, JY; Hinkle, G; Jhiang, SM; Kloos, RT; Marsee, DK; Nagaraja, HN; Schaap, J; Shen, DH; Yang, W | 1 |
| Batista, JF; Casaco, A; Coca, MA; Fernandez, R; García, I; Hernández, A; Leyva, R; Lopez, G; Peña, Y; Perera, A; Prats, A; Romero, S; Sanchez, Y; Torres, LA | 1 |
| Amador, Z; Batista, J; Casacó, A; Coca, M; Estupiñan, B; Fernández, R; Figueredo, J; García, I; González, A; Hernández, A; Iglesias, M; Leyva, R; López, G; Peña, Y; Perera, A; Puig, M; Ramos, M; Rodríguez, JA; Rodríquez, L; Suarez, N; Torres, L | 1 |
| Betti, O; Schlienger, M; Szenthe, L; Szikla, G | 1 |
2 trial(s) available for rhenium and Glioma
| Article | Year |
|---|---|
Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Body Burden; Brain Neoplasms; Dose-Response Relationship, Radiation; Female; Glioma; Humans; Male; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Radiation Dosage; Radiation Injuries; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2008 |
Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188 Re in adult recurrent high-grade glioma.
Topics: Adult; Aged; Antibodies, Monoclonal; Brain Neoplasms; Clinical Trials, Phase II as Topic; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Radioisotopes; Rhenium | 2008 |
9 other study(ies) available for rhenium and Glioma
| Article | Year |
|---|---|
Theranostic studies of human sodium iodide symporter imaging and therapy using 188Re: a human glioma study in mice.
Topics: Animals; Brain Neoplasms; Diagnostic Imaging; Genetic Therapy; Genetic Vectors; Glioma; Humans; Mice; Radionuclide Imaging; Rhenium; Symporters; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.
Topics: Animals; Glioma; Liposomes; Nanoparticles; Neoplasms, Experimental; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rhenium; Tissue Distribution | 2015 |
(99m)Tc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Glioma; Humans; Ligands; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Molecular Conformation; Neoplasms; Organometallic Compounds; Prostatic Neoplasms; Receptors, sigma; Rhenium; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2016 |
Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with (188)Re-lipid nanocapsules.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Glioma; Immunosuppression Therapy; Lipids; Materials Testing; Nanocapsules; Radioisotopes; Rats; Rats, Inbred F344; Rhenium; Survival Rate; Survivors; Tissue Distribution | 2011 |
Imaging, autoradiography, and biodistribution of (188)Re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat model.
Topics: Animals; Autoradiography; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Glioma; Isotope Labeling; Liposomes; Male; Nanoparticles; Radioisotopes; Radiopharmaceuticals; Rats; Rhenium; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2011 |
Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma.
Topics: Animals; Brachytherapy; Brain Neoplasms; Convection; Glioblastoma; Glioma; Liposomes; Nanoparticles; Radioisotopes; Rats; Rhenium; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Nanoparticles for treating brain tumors: unlimited possibilities.
Topics: Animals; Brachytherapy; Brain Neoplasms; Glioblastoma; Glioma; Radioisotopes; Rhenium | 2012 |
Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.
Topics: Animals; Brain Neoplasms; Dose-Response Relationship, Radiation; Genetic Therapy; Glioma; Humans; Iodine Radioisotopes; Male; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Inbred F344; Rhenium; Symporters; Time Factors; Transduction, Genetic | 2004 |
[Current experience of stereotaxic irradiations in the treatment of hemispheric gliomas (author's transl)].
Topics: Adolescent; Adult; Brain Neoplasms; Glioma; Humans; Middle Aged; Radioisotopes; Rhenium; Stereotaxic Techniques; Yttrium Radioisotopes | 1981 |